Abbott Alinity m HR-HPV, a novel human papillomavirus assay for primary cervical cancer screening, is adapted to HPV guidelines
Guardado en:
Autores principales: | Lina Mouna, Coralie Pallier, Claire Deback, Stéphanie Proust, Corinne Hottelet, Sophie Prevot, Anne-Marie Roque-Afonso |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd9a2f13c70c4d3c87867b06d9263062 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A simple and rapid diagnostic method for 13 types of high-risk human papillomavirus (HR-HPV) detection using CRISPR-Cas12a technology
por: Jiaojiao Gong, et al.
Publicado: (2021) -
Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.
por: Sarah Preisler, et al.
Publicado: (2013) -
Assessing survival rate of HPV-positive and HPV-negative cervical cancer patients
por: M. K. Ibragimova, et al.
Publicado: (2019) -
Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Christian T. Fontan, et al.
Publicado: (2020) -
High risk serotypes of the human papillomavirus (HPV) in patients with exofitic lesions in the oral cavity
por: Adel Martínez-Martínez, et al.
Publicado: (2018)